James J. Barry's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 602 Bio-Rad A Common Stock done . Disclosure was reported to the exchange on Sept. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 602 | 748 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 250 | 502 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 297.88 per share. | 01 Sep 2025 | 217 | 531 (0%) | 0% | 297.9 | 64,640 | Bio-Rad A Common Stock |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 178 | 0 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 174 | 174 | - | - | Restricted Stock Units | |
| LivaNova PLC | James Christopher Barry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2025 | 4,042 | 4,042 | - | - | Restricted Stock Units | |
| LivaNova PLC | James Christopher Barry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 3,416 | 0 | - | - | Restricted Stock Units | |
| LivaNova PLC | James Christopher Barry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 3,416 | 4,772 (0%) | 0% | 0 | Ordinary Shares | |
| LivaNova PLC | James Christopher Barry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.76 per share. | 15 Jun 2025 | 410 | 4,362 (0%) | 0% | 45.8 | 18,762 | Ordinary Shares |
| Smartstop Self Storage REI... | James R. Barry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 19,895 | 19,895 | - | - | Long-Term Incentive Plan Units | |
| Smartstop Self Storage REI... | James R. Barry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 9,424 | 9,424 | - | - | Long- Term Incentive Plan Units | |
| Smartstop Self Storage REI... | James R. Barry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 22,625 | 98,276 | - | - | Long-Term Incentive Plan Units | |
| Smartstop Self Storage REI... | James R. Barry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 22,288 | 77,413 | - | - | Long-Term Incentive Plan Units | |
| Smartstop Self Storage REI... | James R. Barry | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 3,793 | 55,125 | - | - | Long-Term Incentive Plan Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,918 | 2,918 | - | - | Non-Qualified Stock Option (right to buy) | |
| LivaNova PLC | James Christopher Barry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,709 | 0 | - | - | Restricted Stock Units | |
| LivaNova PLC | James Christopher Barry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,709 | 1,709 (0%) | 0% | 0 | Ordinary Shares | |
| LivaNova PLC | James Christopher Barry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.50 per share. | 15 Dec 2024 | 353 | 1,356 (0%) | 0% | 51.5 | 18,180 | Ordinary Shares |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 4,224 | 4,224 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Sale of securities on an exchange or to another person at price $ 330.49 per share. | 01 Sep 2024 | 623 | 146 (0%) | 0% | 330.5 | 205,898 | Bio-Rad A Common Stock |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 265 | 725 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 265 | 0 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 250 | 752 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 250 | 326 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 217 | 847 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 217 | 0 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 177 | 524 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 177 | 178 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 173 | 348 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 173 | 409 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 95 | 630 (0%) | 0% | 337.3 | 32,045 | Bio-Rad A Common Stock |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 90 | 236 (0%) | 0% | 337.3 | 30,359 | Bio-Rad A Common Stock |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.31 per share. | 01 Sep 2024 | 78 | 769 (0%) | 0% | 334.3 | 26,076 | Bio-Rad A Common Stock |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.31 per share. | 01 Sep 2024 | 64 | 460 (0%) | 0% | 337.3 | 21,588 | Bio-Rad A Common Stock |
| BioRad Laboratories Inc | James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 62 | 347 (0%) | 0% | 337.3 | 20,914 | Bio-Rad A Common Stock |
| LivaNova PLC | James Christopher Barry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2024 | 3,416 | 3,416 | - | - | Restricted Stock Units | |
| LivaNova PLC | James Barry Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 1,709 | 1,709 | - | - | Restricted Stock Units | |
| Biosig Technologies Inc | Barry J. James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 12,000 | 71,249 (0%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | James J. Barry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 13,158 | 59,249 (0%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | James J. Barry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 12,000 | 46,091 (0%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | James J. Barry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 34,091 | 34,091 (0%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | James J. Barry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |